Cargando…
Notch1 phenotype and clinical stage progression in non-small cell lung cancer
BACKGROUND: Notch1 transmembrane receptor is activated through ligand-binding- triggered proteolytic cleavages and, upon release, the intracellular domain (N1-ICD) translocates into the nucleus and modulates target gene transcriptions. Notch activation has been implicated in tumorigenesis in an incr...
Autores principales: | Nguyen, Dat, Rubinstein, Larry, Takebe, Naoko, Miele, Lucio, Tomaszewski, Joseph E, Ivy, Percy, Doroshow, James H, Yang, Sherry X |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343190/ https://www.ncbi.nlm.nih.gov/pubmed/25653136 http://dx.doi.org/10.1186/s13045-014-0104-2 |
Ejemplares similares
-
TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models
por: Yang, Sherry X., et al.
Publicado: (2021) -
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition
por: Takebe, Naoko, et al.
Publicado: (2011) -
Notch Signaling in Neuroendocrine Tumors
por: Crabtree, Judy S., et al.
Publicado: (2016) -
Modeling Pharmacodynamic Response to the Poly(ADP-Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells
por: Ji, Jiuping, et al.
Publicado: (2011) -
DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors
por: Laranjeira, Angelo B. A., et al.
Publicado: (2023)